By Biosynth
Subscribe to Supplier
Subscribe to Supplier
Biosynth showcasing raw materials portfolio at CACLP China expo
Staad, Switzerland: – Biosynth is an innovative life sciences reagents, custom synthesis and manufacturing services company. Biosynth AG will be an exhibitor at the 20th China Association of Clinical Laboratory Practice Expo (CACLP) in Chongqing.
The Biosynth stand at Booth N8-0428 in the Nanchang Greenland International Expo Center will showcase its contributions to shaping the future of the in-vitro diagnostics IVD industry.
Innovative Solutions
The stand will feature examples of Biosynth’s huge range of raw materials and reagents, as well as its innovative solutions for clinical and veterinary diagnostics. With more than 45,000 antibodies and antigens in its catalog, including bulk and custom supply options, Biosynth is constantly adapting to meet the demands of emerging infectious diseases in humans and animals.
The stand will also feature the work of Biosynth’s Biologics Division as a source of innovative tools for the developing IVD industry. Examples include a range of more sustainable and reproducible replacements for BSA and FBS, innovative novel Human Hybrid IgM Monoclonal Antibodies as an alternative to hard-to-find human disease state IgM plasma, and veterinary products including for the detection of Cache Valley and Kairi.
About Biosynth
Biosynth is a supplier of critical raw materials, and services for diagnostics, vaccines and pharmaceuticals with global research, manufacturing, and distribution facilities. Supplying the pharmaceutical and diagnostic sectors; where Chemistry meets Biology, Products meet Services and Innovation meets Quality, Biosynth is at the Edge of Innovation.
With an unrivaled research product portfolio of over a million products and end-to-end manufacturing services, Biosynth’s expertise and capability spans Complex Chemicals, Peptides, and Key Biologics, all from one trusted partner. Headquartered in Staad, Switzerland, Biosynth is owned amongst others by KKR, Ampersand Capital Partners, and management.
Find out more about Biosynth at www.biosynth.com
About CACLP 2024
The annual China Association of Clinical Laboratory Practice Expo (CACLP) is billed as the world’s leading exhibition for the in vitro diagnostics industry, attracting some 40,000 visitors from around 30 countries, and more than 1,300 exhibitors.
The 20th CACLP Expo, twinned with the 3rd China IVD Supply Chain Expo (CISCE), is a three-day event opening March 16, 2024, at the Chongqing International Expo Center.
The CACLP show is organized in seven product categories, including molecular diagnostics, clinical diagnosis, immunodiagnostics, biochemical diagnosis, microbiological diagnostics, raw materials, and POCT.
At the same time, the Expo will host a series of more than 20 academic conferences with themes ranging across experimental medicine, biomedical engineering, molecular diagnosis to pathology, mass spectrometry, blood transfusion, clinical & laboratory research, and other IVD-related topics.
The event is organized by CACLP with further information at: https://en.caclp.com
Resources
Click on Biosynth at CACLP 2024 to see exhibitor profile.
Click on Supplying Critical Raw Materials and Services for Diagnostics, Vaccines and Pharmaceuticals for further information.
Related Articles
